Neothetics to Releas
Neothetics to Release First Quarter 2015 Financial Results, Host Annual Stockholder Meeting
07 mai 2015 08h00 HE | Neothetics, Inc.
SAN DIEGO, May 7, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced that it...
Neothetics Initiates
Neothetics Initiates Pivotal Phase 3 Clinical Trials for LIPO-202, the First Non-Invasive Injectable Drug Candidate for Reduction of Subcutaneous Abdominal Fat
13 avr. 2015 08h00 HE | Neothetics, Inc.
SAN DIEGO, April 13, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced the...
Neothetics to Presen
Neothetics to Present at Needham & Company's 14th Annual Healthcare Conference
08 avr. 2015 08h00 HE | Neothetics, Inc.
SAN DIEGO, April 8, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced that...
Neothetics Reports F
Neothetics Reports Fourth Quarter and Full Year 2014 Financial Results
26 mars 2015 08h00 HE | Neothetics, Inc.
SAN DIEGO, March 26, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today reported...
Neothetics Initiates
Neothetics Initiates Study to Evaluate Safety of Retreatment With LIPO-202 for Body Contouring
23 mars 2015 09h30 HE | Neothetics, Inc.
SAN DIEGO, March 23, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced it has...
Neothetics to Presen
Neothetics to Present at the 27th Annual Roth Conference
04 mars 2015 08h00 HE | Neothetics, Inc.
SAN DIEGO, March 4, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced that...
Neothetics to Presen
Neothetics to Present at Cowen and Company 35th Annual Health Care Conference
25 févr. 2015 08h00 HE | Neothetics, Inc.
SAN DIEGO, Feb. 25, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced that...
Leading Aesthetic Ph
Leading Aesthetic Physicians Join Neothetics' Newly Formed Corporate Advisory Board
12 févr. 2015 08h00 HE | Neothetics, Inc.
SAN DIEGO, Feb. 12, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced the...
Neothetics Announces
Neothetics Announces Closing of Upsized Initial Public Offering
01 déc. 2014 08h00 HE | Neothetics, Inc.
SAN DIEGO, Dec. 1, 2014 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced the...
Neothetics Prices In
Neothetics Prices Initial Public Offering
19 nov. 2014 19h35 HE | Neothetics, Inc.
SAN DIEGO, Nov. 19, 2014 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced the...